A federal judge denied health insurer Humana’s request to dismiss an Alabama health system’s suit against its Medicare Advantage plans [...] Read More »
Articles by : Rich Daly, Editor in Chief
One-fifth of 340B hospitals will garner no repayment from Medicare for past underpayments, according to a recent analysis by a [...] Read More »
Cosette Pharmaceuticals recently announced refunds to 340B covered entities for 38 medications sold over a year and half. The refunds [...] Read More »
As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...] Read More »
Japanese drugmaker Takeda recently announced refunds to 340B covered entities for 28 drugs, including one of its top-selling attention-deficit medications. [...] Read More »
Following the recent death of former Arkansas governor and U.S. Sen. David Pryor, he is being remembered for his important [...] Read More »
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...] Read More »
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] Read More »
Sen. John Thune (R-S.D.), who is spearheading a major bipartisan 340B reform package, told hospital executives Tuesday that 340B legislation [...] Read More »
Federal regulators recently said any decision on whether to provide Medicare Advantage (MA) plans funds to reimburse hospitals for past [...] Read More »